Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
111.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (0.901%)
Market Cap: £67.08m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Intercede Collaborates with Microsoft and Yubico

1 May 2025 07:00

RNS Number : 8306G
Intercede Group PLC
01 May 2025
 

RNS Reach

1 May 2025

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

Intercede Collaborates with Microsoft and Yubico to Enhance Enterprise Security with Stronger Authentication

Intercede, a pioneering digital identity management company, today announced the launch of its latest version of MyID CMS that enables the management of Passkeys with Microsoft Entra ID. Administrators can now use the credentials management system to seamlessly manage FIDO Passkeys on devices including the Yubico YubiKey family of products, that can then be used to securely authenticate to Entra ID protected resources.

The solution enables organisations to use seamless, secure authentication processes by combining the strengths of the Intercede, Yubico, and Microsoft technology platforms. By integrating Entra ID's robust FIDO2 provisioning API's with MyID CMS and YubiKeys, enterprises can now implement an end-to-end secure issuance and life cycle management solution for FIDO Passkeys, whether in Cloud or Hybrid Entra ID solutions, manage PKI and FIDO credentials on a single YubiKey, as well as support for using a Passkey as a Derived Credential.

Key highlights of MyID 12.14 Entra ID Capabilities:

· Compliance with NIST SP800-63B digital identity guidelines

· Simplified FIDO passkey issuance and lifecycle management

· Manage passkeys alongside other credential types such as certificates

· Applying expiry dates to passkeys - automatically revoke the credential for fixed term workers, or for temporary passkey usage

· Support for passkeys as a derived credential, compliant with NIST SP800-157.

"This collaboration represents a significant step forward in enterprise credential management," said Allen Storey, Chief Product Officer at Intercede. "Our integrated solution enables customers to issue and manage passkeys at the highest level of security in compliance with NIST standards, making the use of passkeys in high-assurance environments a reality."

Natee Pretikul, Principal Product Management Lead at Microsoft Security, commented: "At Microsoft, we are committed to transforming enterprise security through the implementation of passkey technology with Entra ID. Our newly developed FIDO2 provisioning APIs, coupled with collaborations with industry partners such as Intercede and Yubico, enable us to deliver comprehensive authentication solutions that can be deployed and managed at scale." 

Jeff Wallace - SVP Product at Yubico, stated: "By integrating Yubico's trusted hardware-based authentication in the YubiKey with Intercede's MyID CMS and Microsoft Entra ID, we are empowering organisations to securely manage the lifecycle of FIDO passkeys with a streamlined, end-to-end solution, that also includes previously available authentication protocols." Wallace added: "This collaboration ensures enterprises can uphold the highest security standards while simplifying credential management for both cloud and hybrid environments."

The combined solution addresses growing enterprise needs for robust, flexible, and user-friendly phishing resistant authentication systems. By eliminating traditional complexity in credential management, the collaboration empowers organisations to implement more agile and secure identity verification strategies.

ENQUIRIES

Intercede Group plc

Tel. + 44 (0)1455 558111

Klaas van der Leest

CEO

Nitil Patel

CFO

 

 

Cavendish Capital Markets Limited

Tel. + 44 (0)20 7220 0500

Marc Milmo/Fergus Sullivan/Rory Sale

Corporate Finance

Tim Redfern/ Ondraya Swanson

ECM

 

About Intercede

Intercede is a cybersecurity software company specialising in digital identities and strong authentication, and its innovative solutions enable organisations to protect themselves against the number one cause of data breach: compromised user credentials.

The Intercede suite of products allows customers to choose the level of security that best fits their needs, from Secure Registration and ID Verification to Password Security Management, One-Time Passwords, FIDO and PKI. Uniquely, Intercede provides the entire set of authentication options from Passwords to PKI, supporting customers on their journey to passwordless and stronger authentication environments. In addition to developing and supporting Intercede software, the Group offers professional services and development capabilities as well as managing the world's largest password breach database.

For over 20 years, global customers in government, aerospace and defence, financial services, healthcare, telecommunications, cloud services and information technology have trusted Intercede solutions and expertise in protecting their mission critical data and systems at the highest level of assurance.

For more information visit: www.intercede.com  

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAWPUUWCUPAUBU
Date   Source Headline
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.